Press release
Hepatitis Therapeutics Market Foreseen to Draw a Promising Growth of CAGR by 2025 | Leading Company’s - J&J, Gilead, Bristol-Myers Squibb, Merck, AbbVie
Hepatitis Therapeutics Market
This report provides in-depth study of “Global Hepatitis Therapeutics Market 2020” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Hepatitis Therapeutics Market report also provides an in-depth survey of key players in the market organization.
Major key factors driving the growth of the Global Hepatitis Therapeutics Market are increasing number of hepatitis infected population, rise in the number of autoimmune disease, growing consumption of alcohol & drugs, and improving accessibility to hepatitis drugs and surge in healthcare expenditures across the globe. According to the WHO, around 1.75 million new HCV infections occur each year, and approximately 399,400 deaths were caused due to HCV in 2015. Increase in the usage of unsterilized equipment and infected syringes, medication errors, and transfusion of infectious blood are leading to an increase in the incidence of viral diseases such as Hepatitis C. This, in turn, is likely to fuel demand for hepatitis therapeutics across the globe.
Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/273349 .
Firstly, the report provides a basic overview of the Market including its definition, applications and manufacturing technology. Then, the report explores the international and Chinese major Market players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2020-2025 market shares for each company.
Based on the regional analysis, North America accounted for a major share of the global market in 2017. Increasing incidence of and mortality caused due to hepatitis and increased spending on drugs for the treatment of hepatitis in the U.S. are likely to boost the Hepatitis Therapeutics Market in the region. Europe is anticipated to account for a significant share of the global market between 2018 and 2025. The market in APAC is likely to expand at a significant CAGR during the forecast period. Increasing prevalence of chronic hepatitis C in developing countries such as China and India and favorable government initiatives for creating awareness about hepatitis are projected to propel the market in the region in the next few years.
In the end, the report makes some important proposals for a new project of Hepatitis Therapeutics Market before evaluating its feasibility. Overall, the report provides an in-depth insight of 2013-2025 global Hepatitis Therapeutics market covering all important parameters.
Global Key Vendors:
1 Gilead
2 Johnson & Johnson
3 Bristol-Myers Squibb Company
4 Merck & Co.Inc.
5 AbbVie and More………………….
Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Hepatitis Therapeutics Market Report 2020” @ https://www.businessindustryreports.com/buy-now/273349/single .
Product Type Segmentation
1 Hepatitis Vaccine
2 Anti-Viral Drugs
Industry Segmentation
1 Hepatitis A
2 Hepatitis B
3 Hepatitis C
4 Alcoholic Hepatitis
International Medical Industry News:
Merck (July 06, 2020) - Merck Announces VAR2 Pharmaceuticals as Winner of its Advance Biotech Grant - Merck, a leading science and technology company, today announced that VAR2 Pharmaceuticals has been selected as the European winner of its 2020 Advance Biotech Grant Program. Copenhagen, Denmark-based biotechnology company VAR2 Pharmaceuticals was chosen for its development of a promising novel cancer treatment that has the potential to treat multiple types of human solid tumors.
“Emerging biotech companies play a significant role in the pharma value chain, typically developing therapies for rare and orphan diseases and often need support in bringing these important drugs to market,” said Udit Batra, member of the Merck Executive Board and CEO, Life Science. “VAR2 Pharmaceuticals’ use of a malaria protein to treat cancer is promising, and we are proud to support them.”
VAR2 Pharmaceuticals is in pre-clinical development of a drug conjugate that uses a recombinant malaria protein, rVAR2, to target and combat cancer cells. The rVAR2 protein has been tested on different cancer cell lines and has, in such tests, bound to the vast majority, including melanoma, lymphoma, breast, prostate and ovarian cancer, and Hodgkin's lymphoma. Although today’s focus on Covid-19 vaccines, treatments and diagnostics development is critical, patients around the world need drugs to treat diseases like cancer. With its potential ability to rapidly shrink tumors and target a broad range of cancer cell lines without knowingly disrupting healthy cells, rVAR2 shows promise to be a safe and effective therapy against a broad range of cancers that have virtually no treatment options available.
As part of the grant award, VAR2 Pharmaceuticals will receive in-kind Merck products and consultation support to advance its harvest, downstream, and formulations process development challenges in the production of its drug-conjugated malaria protein.
“We are honored to have been selected as the winner of Merck’s Advance Biotech Grant,” said Ali Salanti, founder and CEO of VAR2 Pharmaceuticals. “The products, process development support and expertise belonging to the Life Science business of Merck in developing biopharmaceutical manufacturing processes will be instrumental in moving this project forward to GMP to enable clinical trials, and we look forward to the collaboration.”
Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/273349 .
Major Points in Table of Contents:
Global Hepatitis Therapeutics Market Report 2020
1 Hepatitis Therapeutics Product Definition
2 Global Hepatitis Therapeutics Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Hepatitis Therapeutics Shipments
2.2 Global Manufacturer Hepatitis Therapeutics Business Revenue
2.3 Global Hepatitis Therapeutics Market Overview
2.4 COVID-19 Impact on Hepatitis Therapeutics Industry
3 Manufacturer Hepatitis Therapeutics Business Introduction
3.1 Gilead Hepatitis Therapeutics Business Introduction
3.2 Johnson & Johnson Hepatitis Therapeutics Business Introduction
3.3 Bristol-Myers Squibb Company Hepatitis Therapeutics Business Introduction
3.4 Merck & Co.Inc. Hepatitis Therapeutics Business Introduction
3.5 AbbVie Inc. Hepatitis Therapeutics Business Introduction
About us
BusinessindustryReports.com is a digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic, and therefore successful decisions for themselves.
Media Contact
Business Industry Reports
Pune – India
sales@businessindustryreports.com
+19376349940
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hepatitis Therapeutics Market Foreseen to Draw a Promising Growth of CAGR by 2025 | Leading Company’s - J&J, Gilead, Bristol-Myers Squibb, Merck, AbbVie here
News-ID: 2095020 • Views: …
More Releases from Business Industry Reports
Tetracaine Market Exhibits a Lucrative Growth Potential during 2021-2025 | Endo …
BusinessIndustryReports has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Tetracaine Market” Research Report 2021 provides an in-depth analysis of the Tetracaine with the forecast of market size and growth. The analysis includes addressable market, market by volume, market share by business type and by segment (external and in-house). The research study examines the Tetracaine on the basis of a number of criteria,…
Cyber Warfare Market Evenly Poised To Reach A Market Value of US$ By Share, Size …
Overview of Global Cyber Warfare Market:
This report provides in-depth study of “Global Cyber Warfare Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cyber Warfare Market report also provides an in-depth survey of key players in the market organization.
According to the market research study, the Cyber Warfare is virtual conflict between state, organization, or country by the use of computer technology to disrupt activities…
Covid-19 Impact on Cranio Maxillofacial Implant Market 2021-2025: Business Growt …
Overview of Global Cranio Maxillofacial Implant Market:
This report provides in-depth study of “Global Cranio Maxillofacial Implant Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cranio Maxillofacial Implant Market report also provides an in-depth survey of key players in the market organization.
According to the market research study, Craniomaxillofacial Implants are medical implants used in surgeries of maxillofacial region such as, head, face, neck, oral,…
Beginning of the bloom: The Rise of the Biohacking Market 2021-2025 | Global Key …
Global Biohacking Market Synopsis:
The report covers a forecast and an analysis of the Biohacking Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Biohacking Market along with the impact they have on the demand over the forecast…
More Releases for Hepatitis
Is Hepatitis A Vaccine Required?
Hepatitis A Vaccine Market describes its growth, size, share, Forecast and trends to 2025
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
Two types of HAV vaccines are currently available internationally:
1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available…
Hepatitis Drugs Market Is Growing Due to Increasing R&D Investments on Hepatitis …
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market
Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Hepatitis B Therapeutics Market Is Driven by Rising Incidence of Hepatitis B In …
Hepatitis B is a life threatening liver infection caused by hepatitis B virus. Adults who get affected by hepatitis B virus for a short time and then get cured is known as acute hepatitis B. Infection that lasts for a long time is known as chronic hepatitis B. Vaccine is the most preferred choice of doctors and physicians to protect people from the disease. The vaccine prevents the infection and…
Hepatitis E Hyperendemicity to Drive Hepatitis E Diagnostic Tests Market Growth
Global Hepatitis E Diagnostic Tests Market: Snapshot
The growing incidence of hepatitis E, a liver disease caused by infection due to the virus hepatitis E virus (HEV), is a leading cause of morbidity and mortality worldwide. There is increasing prevalence of hepatitis E in resource-limited region, such as various countries of Asia Pacific. The people of these regions suffer with frequent water contamination and have limited access to sanitation and hygiene,…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Hepatitis C Drug Pipeline Analysis
“Hepatitis C Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Hepatitis C. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each…
